Masimo (MASI) Stock Forecast & Price Target

Compare

1,236 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MASI Analyst Ratings

Moderate Buy

4 Buy

2 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Masimo

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MASI Stock 12 Month Forecast

Average Price Target

$188.40

▲(38.28% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Masimo in the last 3 months. The average price target is $188.40 with a high forecast of $210.00 and a low forecast of $162.00. The average price target represents a 38.28% change from the last price of $136.25.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"129":"$129","170":"$170","211":"$211","149.5":"$149.5","190.5":"$190.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":210,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$210.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":188.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$188.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":162,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$162.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[129,149.5,170,190.5,211],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.06,136.20923076923077,142.35846153846154,148.5076923076923,154.65692307692308,160.80615384615385,166.95538461538462,173.10461538461539,179.25384615384615,185.40307692307692,191.5523076923077,197.70153846153846,203.85076923076923,{"y":210,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.06,134.5476923076923,139.03538461538463,143.52307692307693,148.01076923076923,152.49846153846153,156.98615384615385,161.47384615384615,165.96153846153845,170.44923076923078,174.93692307692308,179.42461538461538,183.9123076923077,{"y":188.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.06,132.5169230769231,134.97384615384615,137.43076923076924,139.8876923076923,142.3446153846154,144.80153846153846,147.25846153846155,149.7153846153846,152.1723076923077,154.62923076923076,157.08615384615385,159.5430769230769,{"y":162,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":171.69,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.3,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.23,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.61,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.65,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.03,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.01,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.54,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 41, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.02,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 49, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.06,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$210.00

Average Price Target$188.40

Lowest Price Target$162.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jason Bednar

Piper Sandler

$210

Buy

54.13%

Upside

Reiterated

01/20/26

Analysts Are Bullish on Top Healthcare Stocks: IDEAYA Biosciences (IDYA), Masimo (MASI)

Vik Chopra

Wells Fargo

$190

Buy

39.45%

Upside

Reiterated

01/14/26

Masimo (MASI) Receives a Buy from Wells Fargo

Michael Matson

Needham

Hold

―

Reiterated

01/12/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (NASDAQ: ALNY), GeneDx Holdings (NASDAQ: WGS) and Masimo (NASDAQ: MASI)

Marie Thibault

BTIG

$200

Buy

46.79%

Upside

Reiterated

01/12/26

Masimo: Strong Q4 Beat, Upgraded 2025 Outlook, and Expanding Driver Shipments Underpin Buy Rating

Travis Steed

Bank of America Securities

$162

Hold

18.90%

Upside

Reiterated

12/08/25

Masimo (MASI) Gets a Hold from Bank of America Securities

Rick Wise

Stifel Nicolaus

$180

Buy

32.11%

Upside

Reiterated

12/04/25

Analysts Conflicted on These Healthcare Names: Masimo (NASDAQ: MASI), Bristol-Myers Squibb (NYSE: BMY) and Pharvaris (NASDAQ: PHVS)

Jayson Bedford

Raymond James

$185

Buy

35.78%

Upside

Reiterated

08/06/25

Masimo (MASI) Gets a Buy from Raymond James

Matthew Taylor

Jefferies

$158→$170

Hold

24.77%

Upside

Reiterated

08/06/25

Masimo (MASI) Receives a Hold from Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jason Bednar

Piper Sandler

$210

Buy

54.13%

Upside

Reiterated

01/20/26

Analysts Are Bullish on Top Healthcare Stocks: IDEAYA Biosciences (IDYA), Masimo (MASI)

Vik Chopra

Wells Fargo

$190

Buy

39.45%

Upside

Reiterated

01/14/26

Masimo (MASI) Receives a Buy from Wells Fargo

Michael Matson

Needham

Hold

―

Reiterated

01/12/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (NASDAQ: ALNY), GeneDx Holdings (NASDAQ: WGS) and Masimo (NASDAQ: MASI)

Marie Thibault

BTIG

$200

Buy

46.79%

Upside

Reiterated

01/12/26

Masimo: Strong Q4 Beat, Upgraded 2025 Outlook, and Expanding Driver Shipments Underpin Buy Rating

Travis Steed

Bank of America Securities

$162

Hold

18.90%

Upside

Reiterated

12/08/25

Masimo (MASI) Gets a Hold from Bank of America Securities

Rick Wise

Stifel Nicolaus

$180

Buy

32.11%

Upside

Reiterated

12/04/25

Analysts Conflicted on These Healthcare Names: Masimo (NASDAQ: MASI), Bristol-Myers Squibb (NYSE: BMY) and Pharvaris (NASDAQ: PHVS)

Jayson Bedford

Raymond James

$185

Buy

35.78%

Upside

Reiterated

08/06/25

Masimo (MASI) Gets a Buy from Raymond James

Matthew Taylor

Jefferies

$158→$170

Hold

24.77%

Upside

Reiterated

08/06/25

Masimo (MASI) Receives a Hold from Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Masimo

3 Months

xxx

Success Rate

14/32 ratings generated profit

Average Return

+2.83%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 43.75% of your transactions generating a profit, with an average return of +2.83% per trade.

1 Year

Rick WiseStifel Nicolaus

Success Rate

17/32 ratings generated profit

Average Return

+8.81%

reiterated a buy rating 2 months ago

Copying Rick Wise's trades and holding each position for 1 Year would result in 53.13% of your transactions generating a profit, with an average return of +8.81% per trade.

2 Years

xxx

Success Rate

16/31 ratings generated profit

Average Return

+6.50%

reiterated a xxx

rating 20 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 51.61% of your transactions generating a profit, with an average return of +6.50% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MASI Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MASI has received 12 Buy Ratings, 35 Hold Ratings, and 0 Sell Ratings. MASI average Analyst price target in the past 3 months is 188.40.

Each month's total comprises the sum of three months' worth of ratings.

MASI Financial Forecast

MASI Earnings Forecast

Next quarter’s earnings estimate for MASI is $1.48 with a range of $1.44 to $1.55. The previous quarter’s EPS was $1.32. MASI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year MASI has Performed in-line its overall industry.

MASI Sales Forecast

Next quarter’s sales forecast for MASI is $408.01M with a range of $404.50M to $411.55M. The previous quarter’s sales results were $371.50M. MASI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year MASI has Performed in-line its overall industry.

MASI Stock Forecast FAQ

What is MASI’s average 12-month price target, according to analysts?

Based on analyst ratings, Masimo Corp’s 12-month average price target is 188.40.

What is MASI’s upside potential, based on the analysts’ average price target?

Masimo Corp has 38.28% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MASI a Buy, Sell or Hold?

Masimo Corp has a consensus rating of Moderate Buy which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.

What is Masimo Corp’s price target?

The average price target for Masimo Corp is 188.40. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $210.00 ,the lowest forecast is $162.00. The average price target represents 38.28% Increase from the current price of $136.25.

What do analysts say about Masimo Corp?

Masimo Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of MASI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Masimo (MASI) Stock Forecast & Price Target

MASI Analyst Ratings

MASI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Masimo

MASI Analyst Recommendation Trends

MASI Financial Forecast

MASI Earnings Forecast

MASI Sales Forecast

MASI Stock Forecast FAQ

Detailed List of Analyst Forecasts